Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1989 1
1990 1
1992 1
1995 1
1996 5
1997 4
1998 9
1999 12
2000 7
2001 16
2002 14
2003 12
2004 16
2005 10
2006 12
2007 10
2008 17
2009 13
2010 26
2011 27
2012 29
2013 20
2014 24
2015 34
2016 27
2017 29
2018 20
2019 17
2020 30
2021 16
2022 21
2023 31
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

474 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Shitara K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, Chung HC, Kawakami H, Yabusaki H, Lee J, Saito K, Kawaguchi Y, Kamio T, Kojima A, Sugihara M, Yamaguchi K; DESTINY-Gastric01 Investigators. Shitara K, et al. N Engl J Med. 2020 Jun 18;382(25):2419-2430. doi: 10.1056/NEJMoa2004413. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469182 Clinical Trial.
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators. Bang YJ, et al. Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7. Lancet. 2012. PMID: 22226517 Clinical Trial.
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ; CLASSIC trial investigators. Noh SH, et al. Lancet Oncol. 2014 Nov;15(12):1389-96. doi: 10.1016/S1470-2045(14)70473-5. Epub 2014 Oct 15. Lancet Oncol. 2014. PMID: 25439693 Clinical Trial.
Lanthanide-Doped Nanoparticles for Diagnostic Sensing.
Lee SY, Lin M, Lee A, Park YI. Lee SY, et al. Among authors: park yi. Nanomaterials (Basel). 2017 Nov 23;7(12):411. doi: 10.3390/nano7120411. Nanomaterials (Basel). 2017. PMID: 29168770 Free PMC article. Review.
Sugar-hormone cross-talk in anthocyanin biosynthesis.
Das PK, Shin DH, Choi SB, Park YI. Das PK, et al. Among authors: park yi. Mol Cells. 2012 Dec;34(6):501-7. doi: 10.1007/s10059-012-0151-x. Epub 2012 Jul 24. Mol Cells. 2012. PMID: 22936387 Free PMC article. Review.
In Reply to Ahmad et al.
Park YI, Hong CS, Kim K. Park YI, et al. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):287-288. doi: 10.1016/j.ijrobp.2023.05.024. Epub 2023 Aug 11. Int J Radiat Oncol Biol Phys. 2023. PMID: 37574243 No abstract available.
Photosynthesis-dependent anthocyanin pigmentation in Arabidopsis.
Das PK, Geul B, Choi SB, Yoo SD, Park YI. Das PK, et al. Among authors: park yi. Plant Signal Behav. 2011 Jan;6(1):23-5. doi: 10.4161/psb.6.1.14082. Epub 2011 Jan 1. Plant Signal Behav. 2011. PMID: 21248473 Free PMC article. Review.
474 results